Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation Maher A. Abdallah, M.D.,

Slides:

Advertisements

Similar presentations

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.

Advertisements

Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

Fertility and Sterility Volume 97, Issue 3, Pages (March 2012)

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

The normal variabilities of the menstrual cycle

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Michael M. Alper, M.D. Fertility and Sterility

Robot-assisted laparoscopy for infertility treatment: current views

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system Shan Liu, M.D.,

Medical treatment of ectopic pregnancy: a committee opinion

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Partnered sexual activity moderates menstrual cycle–related changes in inflammation markers in healthy women: an exploratory observational study Tierney.

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers Andrea.

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Oocyte cryopreservation

Urinary cytokine and chemokine profiles across the menstrual cycle in healthy reproductive-aged women Brian W. Whitcomb, Ph.D., Sunni L. Mumford, Ph.D.,

Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation Amanda.

Intraoperative and postoperative lower genital tract changes after global endometrial ablation using the Hydro ThermAblator® device Martin Farrugia,

Gadolinium radiologic contrast is a useful alternative for hysterosalpingography in patients with iodine allergy Dorette Noorhasan, M.D., Michael J.

Difference in expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in patients with persistent ovarian cysts Maria Rosaria Raspollini,

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle Nancy J. Kenney,

A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone

Significant elevation of plasma matrix metalloproteinase-9 level and its ratio to matrix metalloproteinase-2 in patients with pelvic inflammatory disease

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Clomiphene citrate at 50: the dawning of assisted reproduction

An employer's experience with infertility coverage: a case study

Introduction Fertility and Sterility

Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients Alayman Hussein, M.B.B.C.H.,

Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: Results of 4,062 intrauterine insemination.

Characterizing the endometrium in unexplained and tubal factor infertility: A multiparametric investigation Edmond C.O. Edi-Osagie, M.D., Mourad W. Seif,

CDB-2914, a novel selective progesterone receptor modulator, differentially regulates endometrial gene expression in the proliferative phase of the menstrual.

Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists José M. López, M.D., Eveline.

Clinical uses of anti-Müllerian hormone assays: pitfalls and promises

Effects of the components of hormone therapy on matrix metalloproteinases in breast- cancer cells: an in vitro study Maher A. Abdallah, M.D., Huda I.

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Website quality assessment: Mistaking apples for oranges

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Artificial neural networks combined with surface-enhanced laser desorption/ionization mass spectra distinguish endometriosis from healthy population

Efficacy of luteinizing hormone activity in patients undergoing in vitro fertilization and treated only with low-dose recombinant choriogonadotropin alfa.

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Amy Criniti, M. D. , Angela Thyer, M. D. , Gregory Chow, M. D

Fertility and Sterility: an evaluation

The menopausal transition

Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B

Current evaluation of amenorrhea

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Melissa C. Yih, M.D.,

Nerve fibers and menstrual cycle in peritoneal endometriosis

Defining the proliferative phase endometrial defect

In vitro sildenafil citrate use as a sperm motility stimulant

Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives compared with normally menstruating women:

Soluble HLA-G in the peritoneal fluid of women with endometriosis

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.

Daniel R. Grow, M.D., Khosro Iromloo, M.D. Fertility and Sterility

Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels Antonio Requena, M.D., María Cruz, Ph.D.,

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Endometrial polyps affect uterine receptivity

Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced- stage endometriosis You Jung Han, M.D., M.S., Han-Na Kim, M.S., Jin-Kook.

P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)

Presentation transcript:

Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation Maher A. Abdallah, M.D., Steven T. Nakajima, M.D., Paul C. Lin, M.D., Cicek Gercel-Taylor, Ph.D. Fertility and Sterility Volume 84, Issue 6, Pages 1766-1767 (December 2005) DOI: 10.1016/j.fertnstert.2005.05.055 Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 (A) Total plasma matrix metalloproteinases (MMP-1) peaks at the midluteal phase of the menstrual cycle and reaches lowest levels at late follicular phase. The active MMP-1 levels follow the same pattern. (B) Total active plasma MMP-9 peaks during menses and reaches lowest levels at midluteal phase. Abdallah. MMP plasma levels in menstrual cycles. Fertil Steril 2005 Fertility and Sterility 2005 84, 1766-1767DOI: (10.1016/j.fertnstert.2005.05.055) Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions